Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Solar Energy Outshines The Competition, But Silver Might Spoil The Party

by Stjepan Kalinic | Jan 23, 2026 | General

Solar power supplied the majority of the growth in U.S. electricity demand last year. The new analysis from global energy think tank Ember showed the importance of this renewable source in meeting surging domestic needs. U.S. electricity demand rose by 135...

Alaska Air Talks Up Demand, But Issues Cautious Profit Outlook

by Lekha Gupta | Jan 23, 2026 | General

Alaska Air Group, Inc. (NYSE:ALK) on Thursday reported mixed fourth-quarter fiscal 2025 results. The company reported sales growth of 3% year over year (Y/Y) to $3.63 billion, which slightly missed the street view of $3.64 billion. Details Fourth-quarter revenue...

Bitcoin Frozen Below $90,000, Ethereum, XRP, Dogecoin Volatile Into $2.1 Billion Options Expiry

by Khyathi Dalal | Jan 23, 2026 | General

Bitcoin remains below $90,000 level as liquidations stand at $207.90 million over the past 24 hours.    Bitcoin ETFs saw $32.1 million in net outflows on Thursday, while Ethereum ETFs reported $41.98 million in net outflows. CryptocurrencyTickerPriceBitcoin(CRYPTO:...
Why Is ‘The Golden Dome’ Supplier Redwire Stock Soaring Friday?

Why Is ‘The Golden Dome’ Supplier Redwire Stock Soaring Friday?

by Kaustubh Bagalkote | Jan 23, 2026 | General

Redwire Corporation (NYSE:RDW) shares are trading higher on Friday after President Donald Trump announced progress on “The Golden Dome” defense initiative. Redwire has positioned itself as a potential supplier for the project. Trump Announces Golden Dome Discussions...

Sanofi Plans Regulatory Filings For Dupixent’s Successor Despite Mixed Data From Pivotal Studies

by Vandana Singh | Jan 23, 2026 | General

On Friday, Sanofi SA (NASDAQ:SNY) shared data from two global phase 3 studies of amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L) to treat atopic dermatitis. Amlitelimab is considered a potential...
« Older Entries
Next Entries »

Recent Posts

  • EXCLUSIVE: Prediction Markets ‘Not A Zero-Sum Game’ – Market Expert Says Sportsbooks Can Still Win
  • Nio, Li, XPeng: Which Chinese EV Stock Has The Most Upside?
  • Trump Makes Rare Post On X To Promote Wife’s Amazon Documentary: President May Not Like Box Office Results
  • Here’s How Much $1000 Invested In United Airlines Holdings 5 Years Ago Would Be Worth Today
  • Here’s How Much You Would Have Made Owning Kinder Morgan Stock In The Last 5 Years

Recent Comments

    Archives

    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.